OK, answers from Dr Pourhassan to my questions :
Q..At what point CytoDyn NEED or PLAN to ask for peer review.
A..The Company has submitted an abstract to ASM MICROBE,
The regulation around ASM is that we can't talk about it ( if we are accepted ). This will be our first peer review ( if we are accepted )..... If accepted we can't publish elsewhere , and meeting is in June 2016.
Q..Do you know when monotherapy may be approve ?.
A..FDA has 30 days to comment on that, which comes March 19 (9 more days )
Q..When , we the shareholders will know if Charlie Sheen is a good candidate for this study?
A..We cannot comment about any patients . Patient is free to elaborate on anything they want
Market Data 
Markets 
